Is bronchoscopy always justified in diagnosis of haemoptysis? Response to the letter of Tamura et al. by Torbiarczyk, Justyna Maria et al.
LETTERS TO THE EDITOR
111www.journals.viamedica.pl
Address for correspondence: Wojciech J. Piotrowski, Department of Pneumology and Allergy, 1st Chair of Internal Medicine, Medical University of Lodz, 22 Kopcinski avenue, 
90–153 Lodz, Polska
DOI: 10.5603/ARM.2018.0017
Received: 23.04.2018
Copyright © 2018 PTChP
ISSN 2451–4934
Justyna Torbiarczyk1, Patryk Sobczak1, Katarzyna Torbiarczyk1, Joanna Miłkowska-Dymanowska1, 
Adam Antczak2, Paweł Górski1, Adam J. Białas1, Wojciech J. Piotrowski1
1Department of Pneumology and Allergy, 1st	Chair	of	Internal	Medicine,	Medical	University	of	Lodz,	Poland
2Department	of	General	and	Oncological	Pulmonology,	Medical	University	of	Lodz,	Poland
Is bronchoscopy always justified in diagnosis of haemoptysis? 
Response to the letter of Tamura et al. 
Dear Professor Satoh and Co-authors,
Thank you very much for your interest in our 
recent study on the use of bronchoscopy for eval-
uation of bleeding. In order to resolve all doubts, 
please let us respond point by point:
1. We would like to confirm, that patients with 
active bleeding were not different concerning 
the age from non-actively bleeding patients 
(patients who reported bleeding, but with-
out visible bleeding sites in bronchoscopic 
examination). The age of 59 is not a cut-off, 
but median age for both groups (patients with 
active bleeding and without visible, active 
bleeding).
2. We used the term “no visible abnormalities” 
to describe patients which bronchial tree 
visualized during FOB appeared to be com-
pletely normal in terms of anatomy, bronchial 
mucosa, secretions etc. Therefore, these pa-
tients not only had no signs of bleeding but 
also no signs of any bronchial pathology in 
FOB. We confirm, that patients with “no vis-
ible abnormalities” were younger, comparing 
to patients with any abnormal signs. This 
observation seems logic to us, as younger 
patients have lower risk of plethora of respi-
ratory diseases, i.e. chronic bronchitis. Con-
trary to your suggestion, we do not provide 
any data showing the higher occurrence of 
pathology with high frequency of bleeding 
in younger patients. We suppose, this may 
be just the opposite.
3. The location of bleeding was not specifically 
addressed in our study, due to low number 
of patients with active bleeding.
We are aware of several limitations of our stu-
dy. All the more, we are very grateful for initiation 
of discussion on the role of bronchoscopy for eva-
luation of bleeding from respiratory tract. We wo-
uld like to state clearly, that we do not neglect the 
role of bronchoscopy in this important indication. 
However, prospective studies are needed to define 
these indications in specific clinical situations.
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